ScaleReady is a leading biotechnology company specializing in the development and scaling of cell and gene therapies. With a focus on enhancing the efficiency and effectiveness of biomanufacturing processes, ScaleReady offers innovative solutions that cater to the needs of the rapidly evolving therapeutic landscape.

The company provides advanced manufacturing platforms and automation technologies designed to streamline the production of cell-based therapies, ensuring consistency, quality, and scalability. ScaleReady's expertise encompasses a range of applications, including CAR-T cell therapies and other engineered cell products, allowing for more accessible and cost-effective solutions in the biotech industry.

One of ScaleReady's standout initiatives is the G-Rex Grant Program, a $20 million initiative aimed at advancing cell and gene-modified cell therapy development. This program awards grants to support companies in their manufacturing efforts, providing financial resources and access to a consortium of partners with expertise in cGMP manufacturing, quality control, and regulatory affairs.